.png)
Peptide Therapeutics Market by Type, Type of Manufacturers, Route of Administration, Application & Technology - Global Industry Analysis and Forecast to 2027
Published On : April 2018 Pages : 120 Category: Pharmaceuticals Report Code : HC04678
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Outlook and Trend Analysis
Expanding prevalence of cancer and metabolic disorders, for example, obesity, diabetes, and osteoporosis are the key variables contributing toward the adoption of peptide therapeutics over the conjecture time frame. The demand for low-cost and efficient drugs is high because of developing base of affected paediatric populace and predominance of target diseases in countries with a low income. The development is specifically connected with rising interests in drug revelation.
Application Outlook and Trend Analysis
The cancer section ruled in 2017 with revenue share of over USD 1.85 billion. Expanding prevalence of cancer worldwide and expanding prescription of peptide therapeutics for malignancy treatment are the key components in charge of predominance in this fragment. Rising demand for rapid-acting and efficient therapeutics is foreseen to highlight development.
Type Outlook and Trend Analysis
The innovative peptides ruled in 2017 and held a share of around 66.93%, inferable from the expanding ventures by vast pharmaceuticals in R&D for the improvement of novel drugs and high prescription rate. Nonetheless, generics are expected to encounter lucrative growth over the conjecture time frame.
Manufacturing type Outlook and Trend Analysis
The in-house manufacturing section held the biggest share representing more than 60.0% in 2017. Majority of the key players are engaged with developing peptide therapeutics in-house attributable to stringent regulations and increasing expenses of outsourcing. As huge pharmaceutical organizations have legitimate infrastructure for large-scale manufacturing and advanced technology, these organizations favour in-house manufacturing.
Route of administration Outlook and Trend Analysis
The biopharmaceuticals giants are constantly examining new techniques for drug delivery suitable to peptides. Novel drug delivery technologies are presently being evaluated for efficacy with engineered molecules containing advanced PEGylation, trying to enhance performance of drug delivery performance through better methods of drug delivery. Parenteral course of administration commanded in 2017 with a significant share of the market.
Synthesis Technology Outlook and Trend Analysis
The LPPS section ruled with share of more than 45.0% in 2017 attributable to existence of growing demand for unadulterated peptides for improvement of effective therapeutics. Nonetheless, issues, for example, higher usage of time are in charge of switching preferences of consumers to effective and faster methods, for example, SPPS.
Regional Outlook and Trend Analysis
North America commanded the market in 2017. Increasing awareness levels relating to peptide therapeutics products, expanding interest for diagnostics in cancer and other diseases, and developing biotechnology sector are the components contributing toward the strength. Expanding R&D expenditure by government is additionally assessed to enable peptide therapeutics to keep up predominance over the coming years.
Competitive Insights
The leading players in the market are Sanofi, Lonza Group, GlaxoSmithKline, Pfizer, Eli Lilly and Company, Novo Nordisk, Teva Pharmaceutical Industries, Novartis, Takeda Pharmaceutical Company, Bristol-Myers Squibb, AstraZeneca and Amgen. Improvement of new products and adopting technological progressions are key methods attempted by the organizations to maintain market position. In addition, expanding collaborations for undertaking trials of new drugs is evaluated to increment competition.
The Peptide Therapeutics Market is segmented as follows-
By Application:
- Metabolic
- Respiratory
- Anti-infection
- Dermatology
- Renal
- Cancers
- Cardiovascular Disorder
- GIT
- Pain
- CNS
- Others
By Type:
- Innovative
- Generic
By Type of Manufacturers:
- Outsourced
- In-house
By Route of Administration:
- Oral Route
- Mucosal
- Parenteral Route
- Pulmonary
- Others
By Synthesis Technology:
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Peptide Therapeutics Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Generic
o Innovative
· Peptide Therapeutics Market, By Type of Manufacturers, Estimates and Forecast, 2017-2027 ($Million)
o In-house
o Outsourced
· Peptide Therapeutics Market, By Route of Administration, Estimates and Forecast, 2017-2027 ($Million)
o Parenteral Route
o Oral Route
o Pulmonary
o Mucosal
o Other Route of Administrations
· Peptide Therapeutics Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Cancers
o Metabolic
o Cardiovascular Disorder
o Respiratory
o GIT
o Anti-infection
o Pain
o Dermatology
o CNS
o Renal
o Other Applications
· Peptide Therapeutics Market, By Technology, Estimates and Forecast, 2017-2027 ($Million)
o Solid Phase Peptide Synthesis (SPPS)
o Liquid Phase Peptide Synthesis (LPPS)
o Hybrid Technology
· Peptide Therapeutics Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Peptide Therapeutics Market, By Country
o U.S. Peptide Therapeutics Market
o Canada Peptide Therapeutics Market
o Mexico Peptide Therapeutics Market
o Europe
§ Europe Peptide Therapeutics Market, By Country
o Germany Peptide Therapeutics Market
o UK Peptide Therapeutics Market
o France Peptide Therapeutics Market
o Russia Peptide Therapeutics Market
o Italy Peptide Therapeutics Market
o Rest of Europe Peptide Therapeutics Market
o Asia-Pacific
§ Asia-Pacific Peptide Therapeutics Market, By Country
o China Peptide Therapeutics Market
o Japan Peptide Therapeutics Market
o South Korea Peptide Therapeutics Market
o India Peptide Therapeutics Market
o Southeast Asia Peptide Therapeutics Market
o Rest of Asia-Pacific Peptide Therapeutics Market
o South America
§ South America Peptide Therapeutics Market
o Brazil Peptide Therapeutics Market
o Argentina Peptide Therapeutics Market
o Columbia Peptide Therapeutics Market
o South Africa Peptide Therapeutics Market
o Rest of South America Peptide Therapeutics Market
o Middle East and Africa
§ Middle East and Africa Peptide Therapeutics Market
o Saudi Arabia Peptide Therapeutics Market
o UAE Peptide Therapeutics Market
o Egypt Peptide Therapeutics Market
o Nigeria Peptide Therapeutics Market
o South Africa Peptide Therapeutics Market
o Rest of MEA Peptide Therapeutics Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Peptide Therapeutics Market, By Type
5.1. Introduction
5.2. Global Peptide Therapeutics Revenue and Market Share by Type (2017-2027)
5.2.1. Global Peptide Therapeutics Revenue and Revenue Share by Type (2017-2027)
5.3. Generic
5.3.1. Global Generic Revenue and Growth Rate (2017-2027)
5.4. Innovative
5.4.1. Global Innovative Revenue and Growth Rate (2017-2027)
6. Peptide Therapeutics Market, By Type Of Manufacturers
6.1. Introduction
6.2. Global Peptide Therapeutics Revenue and Market Share by Type Of Manufacturers (2017-2027)
6.2.1. Global Peptide Therapeutics Revenue and Revenue Share by Type Of Manufacturers (2017-2027)
6.3. In-house
6.3.1. Global In-house Revenue and Growth Rate (2017-2027)
6.4. Outsourced
6.4.1. Global Outsourced Revenue and Growth Rate (2017-2027)
7. Peptide Therapeutics Market, By Route Of Administration
7.1. Introduction
7.2. Global Peptide Therapeutics Revenue and Market Share by Route Of Administration (2017-2027)
7.2.1. Global Peptide Therapeutics Revenue and Revenue Share by Route Of Administration (2017-2027)
7.3. Parenteral Route
7.3.1. Global Parenteral Route Revenue and Growth Rate (2017-2027)
7.4. Oral Route
7.4.1. Global Oral Route Revenue and Growth Rate (2017-2027)
7.5. Pulmonary
7.5.1. Global Pulmonary Revenue and Growth Rate (2017-2027)
7.6. Mucosal
7.6.1. Global Mucosal Revenue and Growth Rate (2017-2027)
7.7. Other Route of Administrations
7.7.1. Global Other Route of Administrations Revenue and Growth Rate (2017-2027)
8. Peptide Therapeutics Market, By Application
8.1. Introduction
8.2. Global Peptide Therapeutics Revenue and Market Share by Application (2017-2027)
8.2.1. Global Peptide Therapeutics Revenue and Revenue Share by Application (2017-2027)
8.3. Cancers
8.3.1. Global Cancers Revenue and Growth Rate (2017-2027)
8.4. Metabolic
8.4.1. Global Metabolic Revenue and Growth Rate (2017-2027)
8.5. Cardiovascular Disorder
8.5.1. Global Cardiovascular Disorder Revenue and Growth Rate (2017-2027)
8.6. Respiratory
8.6.1. Global Respiratory Revenue and Growth Rate (2017-2027)
8.7. Other Applications
8.7.1. Global Other Applications Revenue and Growth Rate (2017-2027)
9. Peptide Therapeutics Market, By Technology
9.1. Introduction
9.2. Global Peptide Therapeutics Revenue and Market Share by Technology (2017-2027)
9.2.1. Global Peptide Therapeutics Revenue and Revenue Share by Technology (2017-2027)
9.3. Solid Phase Peptide Synthesis (SPPS)
9.3.1. Global Solid Phase Peptide Synthesis (SPPS) Revenue and Growth Rate (2017-2027)
9.4. Liquid Phase Peptide Synthesis (LPPS)
9.4.1. Global Liquid Phase Peptide Synthesis (LPPS) Revenue and Growth Rate (2017-2027)
9.5. Hybrid Technology
9.5.1. Global Hybrid Technology Revenue and Growth Rate (2017-2027)
10. Peptide Therapeutics Market, By Region
10.1. Introduction
10.2. Global Peptide Therapeutics Revenue and Market Share by Regions
10.2.1. Global Peptide Therapeutics Revenue by Regions (2017-2027)
10.3. North America Peptide Therapeutics by Countries
10.3.1. North America Peptide Therapeutics Revenue and Growth Rate (2017-2027)
10.3.2. North America Peptide Therapeutics Revenue (Million USD) by Countries (2017-2027)
10.3.3. United States
10.3.3.1. United States Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.3.4. Canada
10.3.4.1. Canada Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.3.5. Mexico
10.3.5.1. Mexico Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.4. Europe Peptide Therapeutics by Countries
10.4.1. Europe Peptide Therapeutics Revenue and Growth Rate (2017-2027)
10.4.2. Europe Peptide Therapeutics Revenue (Million USD) by Countries (2017-2027)
10.4.3. Germany
10.4.3.1. Germany Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.4. France
10.4.4.1. France Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.5. UK
10.4.5.1. UK Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.6. Russia
10.4.6.1. Russia Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.7. Italy
10.4.7.1. Italy Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.8. Rest of Europe
10.4.8.1. Rest of Europe Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.5. Asia-Pacific Peptide Therapeutics by Countries
10.5.1. Asia-Pacific Peptide Therapeutics Revenue and Growth Rate (2017-2027)
10.5.2. Asia-Pacific Peptide Therapeutics Revenue (Million USD) by Countries (2017-2027)
10.5.3. China
10.5.3.1. China Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.4. Japan
10.5.4.1. Japan Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.5. Korea
10.5.5.1. Korea Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.6. India
10.5.6.1. India Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.7. Southeast Asia
10.5.7.1. Southeast Asia Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.8. Rest of Asia-Pacific
10.5.8.1. Rest of Asia-Pacific Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.6. South America Peptide Therapeutics by Countries
10.6.1. South America Peptide Therapeutics Revenue and Growth Rate (2017-2027)
10.6.2. South America Peptide Therapeutics Revenue (Million USD) by Countries (2017-2027)
10.6.3. Brazil
10.6.3.1. Brazil Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.6.4. Argentina
10.6.4.1. Argentina Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.6.5. Columbia
10.6.5.1. Columbia Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.6.6. Rest of South America
10.6.6.1. Rest of South America Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.7. Middle East and Africa Peptide Therapeutics by Countries
10.7.1. Middle East and Africa Peptide Therapeutics Revenue and Growth Rate (2017-2027)
10.7.2. Middle East and Africa Peptide Therapeutics Revenue (Million USD) by Countries (2017-2027)
10.7.3. Saudi Arabia
10.7.3.1. Saudi Arabia Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.4. United Arab Emirates
10.7.4.1. United Arab Emirates Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.5. Egypt
10.7.5.1. Egypt Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.6. Nigeria
10.7.6.1. Nigeria Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.7. South Africa
10.7.7.1. South Africa Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.8. Turkey
10.7.8.1. Turkey Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.9. Rest of Middle East and Africa
10.7.9.1. Rest of Middle East and Africa Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
11. Company Profiles
11.1. Bachem Holding AG
11.1.1. Business Overview
11.1.2. Service Portfolio
11.1.3. Strategic Developments
11.1.4. Financial Overview
11.2. Eli Lilly and Company
11.2.1. Business Overview
11.2.2. Service Portfolio
11.2.3. Strategic Developments
11.2.4. Financial Overview
11.3. Pfizer Inc.
11.3.1. Business Overview
11.3.2. Service Portfolio
11.3.3. Strategic Developments
11.3.4. Financial Overview
11.4. Amgen Inc.
11.4.1. Business Overview
11.4.2. Service Portfolio
11.4.3. Strategic Developments
11.4.4. Financial Overview
11.5. Takeda Pharmaceutical Company Limited
11.5.1. Business Overview
11.5.2. Service Portfolio
11.5.3. Strategic Developments
11.5.4. Financial Overview
11.6. Teva Pharmaceutical
11.6.1. Business Overview
11.6.2. Service Portfolio
11.6.3. Strategic Developments
11.6.4. Financial Overview
11.7. Lonza Inc.
11.7.1. Business Overview
11.7.2. Service Portfolio
11.7.3. Strategic Developments
11.7.4. Financial Overview
11.8. Sanofi
11.8.1. Business Overview
11.8.2. Service Portfolio
11.8.3. Strategic Developments
11.8.4. Financial Overview
11.9. Bristol-Myers Squibb(BMS)
11.9.1. Business Overview
11.9.2. Service Portfolio
11.9.3. Strategic Developments
11.9.4. Financial Overview
11.10. AstraZeneca PLC
11.10.1. Business Overview
11.10.2. Service Portfolio
11.10.3. Strategic Developments
11.10.4. Financial Overview
12. Peptide Therapeutics Market Forecast (2017-2027)
12.1. Global Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
12.2. Peptide Therapeutics Market Forecast by Regions (2017-2027)
12.2.1. North America Peptide Therapeutics Market Forecast (2017-2027)
12.2.1.1. United States Peptide Therapeutics Market Forecast (2017-2027)
12.2.1.2. Canada Peptide Therapeutics Market Forecast (2017-2027)
12.2.1.3. Mexico Peptide Therapeutics Market Forecast (2017-2027)
12.2.2. Europe Peptide Therapeutics Market Forecast (2017-2027)
12.2.2.1. Germany Peptide Therapeutics Market Forecast (2017-2027)
12.2.2.2. France Peptide Therapeutics Market Forecast (2017-2027)
12.2.2.3. UK Peptide Therapeutics Market Forecast (2017-2027)
12.2.2.4. Russia Peptide Therapeutics Market Forecast (2017-2027)
12.2.2.5. Italy Peptide Therapeutics Market Forecast (2017-2027)
12.2.2.6. Rest of Europe Peptide Therapeutics Market Forecast (2017-2027)
12.2.3. Asia-Pacific Peptide Therapeutics Market Forecast (2017-2027)
12.2.3.1. China Peptide Therapeutics Market Forecast (2017-2027)
12.2.3.2. Japan Peptide Therapeutics Market Forecast (2017-2027)
12.2.3.3. Korea Peptide Therapeutics Market Forecast (2017-2027)
12.2.3.4. India Peptide Therapeutics Market Forecast (2017-2027)
12.2.3.5. Southeast Asia Peptide Therapeutics Market Forecast (2017-2027)
12.2.3.6. Rest of Asia-Pacific Peptide Therapeutics Market Forecast (2017-2027)
12.2.4. South America Peptide Therapeutics Market Forecast (2017-2027)
12.2.4.1. Brazil Peptide Therapeutics Market Forecast (2017-2027)
12.2.4.2. Argentina Peptide Therapeutics Market Forecast (2017-2027)
12.2.4.3. Columbia Peptide Therapeutics Market Forecast (2017-2027)
12.2.4.4. Rest of South America Peptide Therapeutics Market Forecast (2017-2027)
12.2.5. Middle East and Africa Peptide Therapeutics Market Forecast (2017-2027)
12.2.5.1. Saudi Arabia Peptide Therapeutics Market Forecast (2017-2027)
12.2.5.2. United Arab Emirates Peptide Therapeutics Market Forecast (2017-2027)
12.2.5.3. Egypt Peptide Therapeutics Market Forecast (2017-2027)
12.2.5.4. Nigeria Peptide Therapeutics Market Forecast (2017-2027)
12.2.5.5. South Africa Peptide Therapeutics Market Forecast (2017-2027)
12.2.5.6. Turkey Peptide Therapeutics Market Forecast (2017-2027)
12.2.5.7. Rest of Middle East and Africa Peptide Therapeutics Market Forecast (2017-2027)
12.3. Peptide Therapeutics Market Forecast by Type (2017-2027)
12.3.1. Peptide Therapeutics Forecast by Type (2017-2027)
12.3.2. Peptide Therapeutics Market Share Forecast by Type (2017-2027)
12.4. Peptide Therapeutics Market Forecast by Type Of Manufacturers (2017-2027)
12.4.1. Peptide Therapeutics Forecast by Type Of Manufacturers (2017-2027)
12.4.2. Peptide Therapeutics Market Share Forecast by Type Of Manufacturers (2017-2027)
12.5. Peptide Therapeutics Market Forecast by Route Of Administration (2017-2027)
12.5.1. Peptide Therapeutics Forecast by Route Of Administration (2017-2027)
12.5.2. Peptide Therapeutics Market Share Forecast by Route Of Administration (2017-2027)
12.6. Peptide Therapeutics Market Forecast by Application (2017-2027)
12.6.1. Peptide Therapeutics Forecast by Application (2017-2027)
12.6.2. Peptide Therapeutics Market Share Forecast by Application (2017-2027)
12.7. Peptide Therapeutics Market Forecast by Technology (2017-2027)
12.7.1. Peptide Therapeutics Forecast by Technology (2017-2027)
12.7.2. Peptide Therapeutics Market Share Forecast by Technology (2017-2027)
List of Tables
Figure United States Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Peptide Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Peptide Therapeutics Revenue and Revenue Share by Type (2017-2018)
Figure Global Generic Revenue and Growth Rate (2017-2018)
Figure Global Innovative Revenue and Growth Rate (2017-2018)
Table Global Peptide Therapeutics Revenue and Revenue Share by Type Of Manufacturers (2017-2018)
Figure Global In-house Revenue and Growth Rate (2017-2018)
Figure Global Outsourced Revenue and Growth Rate (2017-2018)
Table Global Peptide Therapeutics Revenue and Revenue Share by Route Of Administration (2017-2018)
Figure Global Parenteral Route Revenue and Growth Rate (2017-2018)
Figure Global Oral Route Revenue and Growth Rate (2017-2018)
Figure Global Pulmonary Revenue and Growth Rate (2017-2018)
Figure Global Mucosal Revenue and Growth Rate (2017-2018)
Figure Global Other Route of Administrations Revenue and Growth Rate (2017-2018)
Table Global Peptide Therapeutics Revenue and Revenue Share by Application (2017-2018)
Figure Global Cancers Revenue and Growth Rate (2017-2018)
Figure Global Metabolic Revenue and Growth Rate (2017-2018)
Figure Global Cardiovascular Disorder Revenue and Growth Rate (2017-2018)
Figure Global Respiratory Revenue and Growth Rate (2017-2018)
Figure Global Other Applications Revenue and Growth Rate (2017-2018)
Table Global Peptide Therapeutics Revenue and Revenue Share by Technology (2017-2018)
Figure Global Solid Phase Peptide Synthesis (SPPS) Revenue and Growth Rate (2017-2018)
Figure Global Liquid Phase Peptide Synthesis (LPPS) Revenue and Growth Rate (2017-2018)
Figure Global Hybrid Technology Revenue and Growth Rate (2017-2018)
Table Global Peptide Therapeutics Revenue by Regions (2017-2018)
Figure North America Peptide Therapeutics Growth Rate (2017-2018)
Figure North America Peptide Therapeutics Revenue and Growth Rate (2017-2018)
Figure North America Peptide Therapeutics by Countries (2017-2018)
Figure North America Peptide Therapeutics Revenue (Million USD) by Countries (2017-2018)
Figure United States Peptide Therapeutics Growth Rate (2017-2018)
Figure United States Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Peptide Therapeutics Growth Rate (2017-2018)
Figure Canada Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Peptide Therapeutics Growth Rate (2017-2018)
Figure Mexico Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Peptide Therapeutics Growth Rate (2017-2018)
Figure Europe Peptide Therapeutics Revenue and Growth Rate (2017-2018)
Figure Europe Peptide Therapeutics by Countries (2017-2018)
Figure Europe Peptide Therapeutics Revenue (Million USD) by Countries (2017-2018)
Figure Germany Peptide Therapeutics Growth Rate (2017-2018)
Figure Germany Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Peptide Therapeutics Growth Rate (2017-2018)
Figure France Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Peptide Therapeutics Growth Rate (2017-2018)
Figure UK Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Peptide Therapeutics Growth Rate (2017-2018)
Figure Russia Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Peptide Therapeutics Growth Rate (2017-2018)
Figure Italy Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Peptide Therapeutics Growth Rate (2017-2018)
Figure Rest of Europe Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Peptide Therapeutics Growth Rate (2017-2018)
Figure Asia-Pacific Peptide Therapeutics Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Peptide Therapeutics by Countries (2017-2018)
Figure Asia-Pacific Peptide Therapeutics Revenue (Million USD) by Countries (2017-2018)
Figure China Peptide Therapeutics Growth Rate (2017-2018)
Figure China Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Peptide Therapeutics Growth Rate (2017-2018)
Figure Japan Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Peptide Therapeutics Growth Rate (2017-2018)
Figure Korea Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Peptide Therapeutics Growth Rate (2017-2018)
Figure India Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Peptide Therapeutics Growth Rate (2017-2018)
Figure Southeast Asia Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Peptide Therapeutics Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Peptide Therapeutics Growth Rate (2017-2018)
Figure South America Peptide Therapeutics Revenue and Growth Rate (2017-2018)
Figure South America Peptide Therapeutics by Countries (2017-2018)
Figure South America Peptide Therapeutics Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Peptide Therapeutics Growth Rate (2017-2018)
Figure Brazil Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Peptide Therapeutics Growth Rate (2017-2018)
Figure Argentina Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Peptide Therapeutics Growth Rate (2017-2018)
Figure Columbia Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Peptide Therapeutics Growth Rate (2017-2018)
Figure Rest of South America Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Peptide Therapeutics Growth Rate (2017-2018)
Figure Middle East and Africa Peptide Therapeutics Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Peptide Therapeutics by Countries (2017-2018)
Figure Middle East and Africa Peptide Therapeutics Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Peptide Therapeutics Growth Rate (2017-2018)
Figure Saudi Arabia Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Peptide Therapeutics Growth Rate (2017-2018)
Figure United Arab Emirates Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Peptide Therapeutics Growth Rate (2017-2018)
Figure Egypt Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Peptide Therapeutics Growth Rate (2017-2018)
Figure Nigeria Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Peptide Therapeutics Growth Rate (2017-2018)
Figure South Africa Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Peptide Therapeutics Growth Rate (2017-2018)
Figure Turkey Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Peptide Therapeutics Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Table Bachem Holding AG Peptide Therapeutics Financial Overview
Table Eli Lilly and Company Peptide Therapeutics Financial Overview
Table Pfizer Inc. Peptide Therapeutics Financial Overview
Table Amgen Inc. Peptide Therapeutics Financial Overview
Table Takeda Pharmaceutical Company Limited Peptide Therapeutics Financial Overview
Table Teva Pharmaceutical Peptide Therapeutics Financial Overview
Table Lonza Inc. Peptide Therapeutics Financial Overview
Table Sanofi Peptide Therapeutics Financial Overview
Table Bristol-Myers Squibb(BMS) Peptide Therapeutics Financial Overview
Table AstraZeneca PLC Peptide Therapeutics Financial Overview
Figure Global Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2018-2025)
Table Peptide Therapeutics Market Forecast by Regions (2018-2025)
Figure North America Peptide Therapeutics Market Forecast (2018-2025)
Figure United States Peptide Therapeutics Market Forecast (2018-2025)
Figure Canada Peptide Therapeutics Market Forecast (2018-2025)
Figure Mexico Peptide Therapeutics Market Forecast (2018-2025)
Figure Europe Peptide Therapeutics Market Forecast (2018-2025)
Figure Germany Peptide Therapeutics Market Forecast (2018-2025)
Figure France Peptide Therapeutics Market Forecast (2018-2025)
Figure UK Peptide Therapeutics Market Forecast (2018-2025)
Figure Russia Peptide Therapeutics Market Forecast (2018-2025)
Figure Italy Peptide Therapeutics Market Forecast (2018-2025)
Figure Rest of Europe Peptide Therapeutics Market Forecast (2018-2025)
Figure Asia-Pacific Peptide Therapeutics Market Forecast (2018-2025)
Figure China Peptide Therapeutics Market Forecast (2018-2025)
Figure Japan Peptide Therapeutics Market Forecast (2018-2025)
Figure Korea Peptide Therapeutics Market Forecast (2018-2025)
Figure India Peptide Therapeutics Market Forecast (2018-2025)
Figure Southeast Asia Peptide Therapeutics Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Peptide Therapeutics Market Forecast (2018-2025)
Figure South America Peptide Therapeutics Market Forecast (2018-2025)
Figure Brazil Peptide Therapeutics Market Forecast (2018-2025)
Figure Argentina Peptide Therapeutics Market Forecast (2018-2025)
Figure Columbia Peptide Therapeutics Market Forecast (2018-2025)
Figure Rest of South America Peptide Therapeutics Market Forecast (2018-2025)
Figure Middle East and Africa Peptide Therapeutics Market Forecast (2018-2025)
Figure Saudi Arabia Peptide Therapeutics Market Forecast (2018-2025)
Figure United Arab Emirates Peptide Therapeutics Market Forecast (2018-2025)
Figure Egypt Peptide Therapeutics Market Forecast (2018-2025)
Figure Nigeria Peptide Therapeutics Market Forecast (2018-2025)
Figure South Africa Peptide Therapeutics Market Forecast (2018-2025)
Figure Turkey Peptide Therapeutics Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Peptide Therapeutics Market Forecast (2018-2025)
Figure Global Peptide Therapeutics Forecast by Type (2018-2025)
Figure Global Peptide Therapeutics Market Share Forecast by Type (2018-2025)
Figure Global Peptide Therapeutics Forecast by Type (2018-2025)
Figure Global Peptide Therapeutics Forecast by Type Of Manufacturers (2018-2025)
Figure Global Peptide Therapeutics Market Share Forecast by Type Of Manufacturers (2018-2025)
Figure Global Peptide Therapeutics Forecast by Type Of Manufacturers (2018-2025)
Figure Global Peptide Therapeutics Forecast by Route Of Administration (2018-2025)
Figure Global Peptide Therapeutics Market Share Forecast by Route Of Administration (2018-2025)
Figure Global Peptide Therapeutics Forecast by Route Of Administration (2018-2025)
Figure Global Peptide Therapeutics Forecast by Application (2018-2025)
Figure Global Peptide Therapeutics Market Share Forecast by Application (2018-2025)
Figure Global Peptide Therapeutics Forecast by Application (2018-2025)
Figure Global Peptide Therapeutics Forecast by Technology (2018-2025)
Figure Global Peptide Therapeutics Market Share Forecast by Technology (2018-2025)
Figure Global Peptide Therapeutics Forecast by Technology (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|